Thiago Santos Carneiro, MD, MPH - Research

Active clinical trials

The main goal of this clinical trial is to check if the treatment is safe and well-tolerated. Researchers will compare the MR-301 active drug group with the placebo group to evaluate the safety and tolerability of the drug. Other measurements鈥�

Investigator: Thiago Santos Carneiro
Status: Accepting Candidates
Ages: 18 Years - 65 Years
Sexes: All

My publications

5 publications

2021

Admission Lymphocytopenia is Associated with Urinary Tract Infection and Nosocomial Infections in Hemorrhagic Stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

鈥�

2020

Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

鈥�

2017

cEEG electrode-related pressure ulcers in acutely hospitalized patients.

Neurology. Clinical practice

鈥�

2016

Association between addressing antiseizure drug side effects and patient-reported medication adherence in epilepsy.

Patient preference and adherence

2016

Patient perceptions of physician-documented quality care in epilepsy.

Epilepsy & behavior : E&B

鈥�

网红黑料